An isolated polypeptide is provided. The isolated polypeptide comprising
an antigen recognition domain capable of specifically binding a CD44
polypeptide as set forth in SEQ ID NO: 2 and incapable of binding a CD44
polypeptide selected from the group consisting of: SEQ ID NO: 4 or 6.